By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eiger Biopharma 



Palo Alto  California    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Segment
Start Up





Company News
Eiger Biopharma Announces Appointment Of Biopharmaceutical Industry Veteran Evan Loh, MD To Its Board Of Directors 9/18/2017 8:05:49 AM
Eiger Biopharma Announces FDA Orphan Drug Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 9/5/2017 8:13:45 AM
Eiger Biopharma To Present At Two Upcoming Investor Conferences 8/30/2017 7:17:21 AM
Eiger Biopharma Reports Second Quarter 2017 Financial Results 8/14/2017 7:56:55 AM
Eiger Biopharma Announces FDA Fast Track Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 7/27/2017 6:37:19 AM
Eiger Biopharma Completes Enrollment In Phase II LIMT HDV Study Of Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 7/24/2017 6:20:15 AM
Eiger Biopharma Announces Sale Of Non-Strategic Assets To Theragene Pharmaceuticals 6/29/2017 8:59:07 AM
Eiger Biopharma Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA To Its Board Of Directors 6/14/2017 8:57:39 AM
Eiger Biopharma Reports Additional Positive Phase II Results From Multiple-Ascending Dose Study Of Exendin 9-39 In Post-Bariatric Hypoglycemia Patients At American Diabetes Association Meeting In San Diego 6/12/2017 6:51:40 AM
Eiger Biopharma Completes Enrollment In Phase II Multiple-Ascending Dose Study Of Exendin 9-39 In Post-Bariatric Hypoglycemia Patients 6/6/2017 7:23:43 AM
12345678
//-->